Shenzhen, China · Founded 2021 · Privately Held (backing)
Developer of biomaterial innovation and application intended for the synthetic biology sector. PAM2L Biotechnologies is based in Shenzhen, China and was founded in 2021. Its last reported valuation was $88.8 million in Jan 2023. It has raised $19.1 million.
Last reported valuation
$88.8M
Oct 2026
Priced at
—
Total raised
$19.1M
Last round
—
Cap table — not yet on record
PAM2L Biotechnologies's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of PAM2L Biotechnologies with a free account
·The complete investor list: 11 names
·Watch PAM2L Biotechnologies: the Monday email on marks, rounds and moves
